RETNLB and inflammatory bowel disease: In IBD cases, the intestinal barrier is compromised, marked by the downregulation of epithelial cadherin within tight junctions, leading to decreased mucus thickness, altered goblet cell function—including mucin 2 and resistin-like molecule β (RELMβ)—, and impaired Paneth cell activity (1).